Articles
-
Managing Cell-Based Potency Assays: From Development To Lifecycle Maintenance
4/24/2012
Characterization of a biological product — which includes the determination of physicochemical properties, biological activity, immunochemical properties, purity and impurities — is necessary to establish the safety and efficacy profile of a given product (ICH Q6B). By Dr. Weihong Wang, manager, Molecular and Cell Biology, Eurofins Lancaster Laboratories
-
Cytotoxic Formulation & Filling
3/26/2012
DSM expanded their commercial-scale sterile pharmaceutical services by offering filling and lyophilization of cytotoxic products.
-
Brochure: Finished Dosage Forms
2/21/2012
DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
-
Brochure: Pharma Sterile Dosage Forms
1/30/2012
DSM offers pharmaceutical and biopharmaceutical customers a lyophilization system with unique benefits. It has the precision to serve increasingly demanding lyophilization cycles, a critical requirement for successful product launches and high commercial yields.
-
Targeting Oncology
5/11/2011
In the search to improve cancer outcomes, each promising advance across the biopharmaceutical frontier comes with challenges as unique as the specific molecular pathway and individual genetic profile it targets.